Related references
Note: Only part of the references are listed.A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer
Gary K. Koski et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer
Allan Hackshaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients
Isabelle Bedrosian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Asymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccines
Susan Bahl et al.
AMERICAN JOURNAL OF SURGERY (2009)
Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ
Yunn-Yi Chen et al.
BMC CANCER (2009)
HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer
Robert E. Roses et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
Grazia Arpino et al.
ENDOCRINE REVIEWS (2008)
Reengineering dendritic cell-based anti-cancer vaccines
Gary K. Koski et al.
IMMUNOLOGICAL REVIEWS (2008)
Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy
Madhuri Kakarala et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
Rulla M. Tamimi et al.
BREAST CANCER RESEARCH (2008)
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
Brian J. Czerniecki et al.
CANCER RESEARCH (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid-derived dendritic cells is mediated by IL-12 production
Shuwen Xu et al.
SURGERY (2006)
Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?
Chandra N. Burge et al.
BREAST (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
AE Ring et al.
BRITISH JOURNAL OF CANCER (2004)
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance
R Schiff et al.
CLINICAL CANCER RESEARCH (2004)
Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients
I Bedrosian et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
SW Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12
CS Schmidt et al.
JOURNAL OF IMMUNOLOGY (2002)
HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4(+) T cell clones
SA Perez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
